Intravenous Immunoglobulin for Unverricht-Lundborg Disease.
Status:
Unknown status
Trial end date:
2017-12-30
Target enrollment:
Participant gender:
Summary
Single patient randomized double blind trial to assess whether intravenous immunoglobulin can
improve the clinical outcome of a case suffering from Unverricht-Lundborg disease.